Correlation between femoral version and severity of hip dysplasia in patients with advanced osteoarthritis prior to total hip arthroplasty. / Correlación entre versión femoral y gravedad de displasia del desarrollo de cadera en pacientes con artrosis avanzada.

INTRODUCTION: Developmental dysplasia of the hip (DDH) is a condition which comprises a number of joint abnormalities, including modifications in femoral version and neck-shaft angle (CCD), as well as a probable progression to osteoarthritis in certain cases. The main objective of this research was to find a correlation between femoral version and severity of DDH in patients with advanced osteoarthritis prior to joint replacement, which has not been previously reported. A secondary aim was to describe the modification of CCD as the severity of DDH increases. MATERIALS AND METHOD: Patients over the age of 15 with dysplastic hips and severe osteoarthritis prior to total hip arthroplasty were assessed between March 2018 and February 2019. Cases with any previous hip surgery were excluded. Anteroposterior pelvis X rays and femoral computed tomography (CT) were performed; femoral version was measured in CT and CCD was evaluated both in X rays (2 observers: A and B) and CT (one observer: musculoskeletal radiologist). Severity of DDH was defined by observers A and B according to Crowe classification in X rays. Statistical analysis was performed on SPSS v.21. Shapiro-Wilk test was used to confirm a normal data distribution. Intraclass correlation coefficient (ICC) determined the level of agreement between observers A and B. Pearson test assessed the correlation between femoral version and Crowe classification (positive if >0.5). Student's t test evaluated the statistical significance, which was defined as P<0.05. RESULTS: One-year assessment; 42 patients (54 hips), 76% women. Mean age 52.7 years. 45 hips completed the imaging set, 9 hips were assessed only with X rays. 48%, 16%, 7% and 28% were classified as Crowe I, II, III and IV (100% interobserver agreement). Crowe classes were grouped as I, II/III and IV due to a low number of cases classified as II and III. Mean femoral version was 21.73°, 26.8° and 43.58°, respectively. ICC between observers A and B for CCD measured in X rays was 0.96. Mean CCD measured in X rays for each group (I, II/III and IV) was 148.11°, 147.7° and 147°, and in CT was 131.21°, 127.9° and 122.14°, respectively. A significant difference was found in femoral version between groups I and IV (P=0.0002) and II/III and IV (P=0.042). Pearson correlation between femoral version and severity of DDH was positive (r=0.52; P=0.0002). A significant difference between CCD measured in CT was found between groups I and IV (P=0.003). CONCLUSIONS: A significant increase in femoral version related to severity of DDH and a positive correlation between these 2features were found. Furthermore, a significant decrease in CCD between groups I and IV measured in CT was revealed. These findings would be helpful for preoperative planning of total hip replacement in osteoarthritis secondary to DDH, because once the surgeon has assessed the severity of DDH on X rays or CT, an increased femoral version could be expected. Therefore, availability of specific implants such as conic, modular or cemented stems is critical, in order to modify the femoral anteversion to normal values in the most severe cases.

Correlación entre versión femoral y gravedad de displasia del desarrollo de cadera en pacientes con artrosis avanzada / Correlation between femoral version and severity of hip dysplasia in patients with advanced osteoarthritis prior to total hip arthroplasty

Antecedentes y objetivo: La displasia del desarrollo de cadera (DDC) es una dolencia que incluye un gran espectro de manifestaciones articulares, tales como alteraciones en la versión femoral y en el ángulo cérvico-diafisiario (ACD), así como una probable progresión a artrosis. El objetivo de este estudio fue buscar una correlación entre la versión femoral y la gravedad de la DDC en pacientes con artrosis. Otro objetivo planteado fue evaluar si se presentan cambios significativos en el valor del ACD a medida que la gravedad de la DDC aumenta. Materiales y método: Entre marzo de 2018 y febrero de 2019 fueron evaluados pacientes mayores de 15 años con DDC, sin cirugías de cadera previas y artrosis grave de cadera en espera de artroplastia total. Se solicitaron radiografías (Rx) de pelvis (anteroposterior) y de cadera (anteroposterior y lateral), así como tomografías axiales computadas (TAC) de cadera y rodilla de las extremidades afectadas, en las cuales se realizó la medición de versión femoral y ACD.La clasificación de Crowe fue utilizada para categorizar la gravedad de la DDC y, al igual que el ACD, fue evaluada en forma independiente por 2observadores. La versión femoral y el ACD en la TAC fueron medidos por un radiólogo especialista en enfermedad musculoesquelética. El análisis estadístico fue realizado con SPSS v. 21. Se consideró un valor significativo de p<0,05. Resultados: Los 42 pacientes que cumplieron los criterios de inclusión asistieron a la evaluación; el 76% era de género femenino, con una edad promedio de 52,7 años. De un total de 54 caderas afectadas, 45 fueron evaluadas con ambos exámenes (Rx y TAC) y 9caderas solo con Rx (uno de ellos falleció por otras causas antes de la TAC). El 48%; 16%; 7% y el 28% de las caderas fueron clasificadas en la Rx como Crowe I, II, III y IV, respectivamente, con una concordancia interobservador del 100%.(AU)

Introduction: Developmental dysplasia of the hip (DDH) is a condition which comprises a number of joint abnormalities, including modifications in femoral version and neck-shaft angle (CCD), as well as a probable progression to osteoarthritis in certain cases. The main objective of this research was to find a correlation between femoral version and severity of DDH in patients with advanced osteoarthritis prior to joint replacement, which has not been previously reported. A secondary aim was to describe the modification of CCD as the severity of DDH increases. Materials and method: Patients over the age of 15 with dysplastic hips and severe osteoarthritis prior to total hip arthroplasty were assessed between March 2018 and February 2019. Cases with any previous hip surgery were excluded. Anteroposterior pelvis X rays and femoral computed tomography (CT) were performed; femoral version was measured in CT and CCD was evaluated both in X rays (2 observers: A and B) and CT (one observer: musculoskeletal radiologist). Severity of DDH was defined by observers A and B according to Crowe classification in X rays. Statistical analysis was performed on SPSS v.21. Shapiro-Wilk test was used to confirm a normal data distribution. Intraclass correlation coefficient (ICC) determined the level of agreement between observers A and B. Pearson test assessed the correlation between femoral version and Crowe classification (positive if >0.5). Student's t test evaluated the statistical significance, which was defined as P<0.05. Results: One-year assessment; 42 patients (54 hips), 76% women. Mean age 52.7 years. 45 hips completed the imaging set, 9 hips were assessed only with X rays. 48%, 16%, 7% and 28% were classified as Crowe I, II, III and IV (100% interobserver agreement). Crowe classes were grouped as I, II/III and IV due to a low number of cases classified as II and III. Mean femoral version was 21.73°, 26.8° and 43.58°, respectively. (AU)

Correlation between femoral version and severity of hip dysplasia in patients with advanced osteoarthritis prior to total hip arthroplasty / Correlación entre versión femoral y gravedad de displasia del desarrollo de cadera en pacientes con artrosis avanzadaS

Introduction: Developmental dysplasia of the hip (DDH) is a condition which comprises a number of joint abnormalities, including modifications in femoral version and neck-shaft angle (CCD), as well as a probable progression to osteoarthritis in certain cases. The main objective of this research was to find a correlation between femoral version and severity of DDH in patients with advanced osteoarthritis prior to joint replacement, which has not been previously reported. A secondary aim was to describe the modification of CCD as the severity of DDH increases. Materials and method: Patients over the age of 15 with dysplastic hips and severe osteoarthritis prior to total hip arthroplasty were assessed between March 2018 and February 2019. Cases with any previous hip surgery were excluded. Anteroposterior pelvis X rays and femoral computed tomography (CT) were performed; femoral version was measured in CT and CCD was evaluated both in X rays (2 observers: A and B) and CT (one observer: musculoskeletal radiologist). Severity of DDH was defined by observers A and B according to Crowe classification in X rays. Statistical analysis was performed on SPSS v.21. Shapiro-Wilk test was used to confirm a normal data distribution. Intraclass correlation coefficient (ICC) determined the level of agreement between observers A and B. Pearson test assessed the correlation between femoral version and Crowe classification (positive if >0.5). Student's t test evaluated the statistical significance, which was defined as P<0.05. Results: One-year assessment; 42 patients (54 hips), 76% women. Mean age 52.7 years. 45 hips completed the imaging set, 9 hips were assessed only with X rays. 48%, 16%, 7% and 28% were classified as Crowe I, II, III and IV (100% interobserver agreement). Crowe classes were grouped as I, II/III and IV due to a low number of cases classified as II and III. Mean femoral version was 21.73°, 26.8° and 43.58°, respectively. (AU)

Antecedentes y objetivo: La displasia del desarrollo de cadera (DDC) es una dolencia que incluye un gran espectro de manifestaciones articulares, tales como alteraciones en la versión femoral y en el ángulo cérvico-diafisiario (ACD), así como una probable progresión a artrosis. El objetivo de este estudio fue buscar una correlación entre la versión femoral y la gravedad de la DDC en pacientes con artrosis. Otro objetivo planteado fue evaluar si se presentan cambios significativos en el valor del ACD a medida que la gravedad de la DDC aumenta. Materiales y método: Entre marzo de 2018 y febrero de 2019 fueron evaluados pacientes mayores de 15 años con DDC, sin cirugías de cadera previas y artrosis grave de cadera en espera de artroplastia total. Se solicitaron radiografías (Rx) de pelvis (anteroposterior) y de cadera (anteroposterior y lateral), así como tomografías axiales computadas (TAC) de cadera y rodilla de las extremidades afectadas, en las cuales se realizó la medición de versión femoral y ACD.La clasificación de Crowe fue utilizada para categorizar la gravedad de la DDC y, al igual que el ACD, fue evaluada en forma independiente por 2observadores. La versión femoral y el ACD en la TAC fueron medidos por un radiólogo especialista en enfermedad musculoesquelética. El análisis estadístico fue realizado con SPSS v. 21. Se consideró un valor significativo de p<0,05. Resultados: Los 42 pacientes que cumplieron los criterios de inclusión asistieron a la evaluación; el 76% era de género femenino, con una edad promedio de 52,7 años. De un total de 54 caderas afectadas, 45 fueron evaluadas con ambos exámenes (Rx y TAC) y 9caderas solo con Rx (uno de ellos falleció por otras causas antes de la TAC). El 48%; 16%; 7% y el 28% de las caderas fueron clasificadas en la Rx como Crowe I, II, III y IV, respectivamente, con una concordancia interobservador del 100%.(AU)

¿Es el tacto rectal una herramienta pronóstica en el cáncer prostático localizado? / Is digital rectal exam a prognostic tool for localized prostate cancer?

Introducción: El tacto rectal es un (TR) es un examen con baja sensibilidad para determinar la presencia de un cáncer prostático (CP). El objetivo de este trabajo es comparar el pronóstico y las características clínico-patológicas de los pacientes con y sin enfermedad palpable en pacientes con CP localizado, sometidos a prostatectomía radical. Materiales y Métodos: Se incluyeron 489 pacientes con CP localizado sometidos a PR entre enero de1999 y agosto de 2003. Los pacientes debían tener un seguimiento mínimo de 36 meses. La información se obtuvo de manera prospectiva. La recidiva bioquímica y la sobrevida fue certificada a través de registros clínicos, entrevista telefónica, certificados de defunción y medición seriada de antígenos prostático específico (APE). Se define recidiva como un APE ≥ 0,4 ng/ml Resultados: Los pacientes con estadio cT2, presentaron mayor edad, APE pre operatorio, porcentaje de muestras comprometidas en la biopsia transrectal, volumen tumoral y porcentaje de tumor en la pieza quirúrgica. No hay diferencias entre los pacientes cT1 y cT2 para el porcentaje de márgenes positivos y Score de Gleason. Se observó recidiva bioquímica en 27 por ciento y 45 por ciento de los pacientes cT1 y cT2 respectivamente. La sobrevida libre de enfermedad a los 4,5 años fue 70 por ciento para los cT1 y 57 por ciento para los cT2. Conclusiones: A pesar del tamizaje con APE y TR y del diagnóstico precoz de CP, nuestros pacientes tienen peores características que las series internacionales, por lo que el pronóstico sería afectado negativamente.

Introduction: Digital rectal examination (DRE) have low sensitivity to determine the presence of a prostate cancer (PC).The aim of this study is to compare the prognosis and clinicopathologic characteristics of patients with and without palpable disease in patients with localized PC who underwent radical prostatectomy. Materials and Methods: We included 489 patients with localized PC who underwent RP between January 1999 and August 2003. Patients should have a minimum follow-up of 36 months. The information was obtained prospectively. Biochemical recurrence and survival was ascertained through clinical records, telephone interviews, health goberment information and serial measurements of prostate-specific antigen (PSA). Relapse is defined as a PSA ≥ 0.4 ng / mlResults: Patients with stage CT2 were older and mayor pre-operative PSA, percentage of samples involved in the transrectal biopsy, tumor volume and percentage of tumor in the surgical specimen. There is no difference between CT1 and CT2 patients for the percentage of positive margins and Gleason score. Biochemical relapse was observed in 27 percent and 45 percent of patients CT1 and CT2, respectively. The disease free survival of 4.5 years was 70 percent to 57 percent for CT1 and the CT2.Conclusions: Despite the screening with PSA and DRE and early diagnosis of CP, our patients have the worst characteristics unlike international series, so the prognosis is adversely affected.